PERNIX THERAPEUTICS HOLDINGS, INC. - FORM 10-K - EX-23.1 - CONSENT - March 10, 2016

Attached files

file filename
EX-21.1 - SUBSIDIARIES - PERNIX THERAPEUTICS HOLDINGS, INC.exh21-1.htm
EX-32.1 - 906 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh32-1.htm
EX-31.2 - CFO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-2.htm
EX-31.1 - CEO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-1.htm
10-K - 10-K - PERNIX THERAPEUTICS HOLDINGS, INC.body10k.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (No. 333-168877, No. 333-167327, No. 333-166062, No. 333-175992, and No. 333-204997), Form S-4 (No. 333-200042) and Forms S-3 (No. 333-186048, No. 333-174629, No. 333-200005, and No. 333-200011) of Pernix Therapeutics Holdings, Inc. of our reports dated March 10, 2016 relating to the consolidated balance sheets of the Company as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive loss, stockholders' equity, and cash flows and the related consolidated statement schedule for each of the three years in the period ending December 31, 2015, and the effectiveness of internal control over financial reporting for the Company as of December 31, 2015.

/s/ Cherry Bekaert LLP

Atlanta, Georgia
March 10, 2016

 

PERNIX THERAPEUTICS HOLDINGS, INC. Reports